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Abstract
Background: Physical activity is associated with improvement in lung function; however, pollution exposure during
physical activity can lead to a transient reduction in lung function. This paradoxical relationship may be linked to altered T
regulatory (Treg) cell activity, which increases with exercise and suppresses airway inflammation, but decreases in
association with exposure to air pollution. To clarify these relationships, we investigated buccal cell DNA methylation of
the forkhead box p3 (FOXP3) gene promoter, a proposed biomarker of Treg activity. We hypothesized that active urban
children would have lower FOXP3 promoter methylation, associated with better lung function compared to non-active
children. We also hypothesized that this relationship would be attenuated by high exposure to the air pollutant black
carbon (BC).
Methods: We performed a cross-sectional study of 135 children ages 9–14 who live in New York City. Activity was
measured across 6 days. BC exposure was assessed by personal monitors worn for two 24-h periods, followed by lung
function assessment. Buccal swabs were collected for DNA methylation analysis of three regions (six CpG sites) in the
FOXP3 promoter.
Results: In multivariable regression models, overall, there was no significant relationship between physical activity and
FOXP3 promoter methylation (p > 0.05). However, in stratified analyses, among children with higher BC exposure
(≥1200 ng/m3), physical activity was associated with 2.37% lower methylation in promoter 2 (CpGs −77, −65,
and −58) (βestimate = −2.37%, p < 0.01) but not among those with lower BC exposure (βestimate = 0.54%, p > 0.05).
Differences across strata were statistically significant (pinteraction = 0.04). Among all children, after controlling for BC
concentration, promoter 2 methylation was associated with reduced FEV1/FVC (βestimate = −0.40%, p < 0.01) and
reduced FEF25–75% (βestimate = −1.46%, p < 0.01).
Conclusions: Physical activity in urban children appeared associated with lower FOXP3 promoter methylation,
a possible indicator of greater Treg function, under conditions of high BC exposure. Reduced FOXP3 promoter
methylation was associated with higher lung function. These findings suggest that physical activity may induce
immunologic benefits, particularly for urban children with greater risk of impaired lung function due to exposure to
higher air pollution. FOXP3 promoter buccal cell methylation may function as a useful biomarker of that benefit.
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Background
While regular physical activity is believed to reduce the
frequency of asthma symptoms [1], exposure to air pol-
lution is a known trigger of asthma [2, 3]. Some studies
suggest that engaging in physical activity in polluted
areas may reduce lung function [4, 5], increase airway
inflammation [6], and increase the risk of developing
asthma [7]. One possible explanation is that increased
minute ventilation during exertion could lead to in-
creased pollutant deposition in the lungs [8, 9]. Yet, the
complex relationship between the benefits of regular
physical activity and the risk associated with pollution
exposure is not well understood.
Physical activity and exercise may improve overall
health and lung function, particularly in individuals with
asthma, by suppressing pro-allergic immune responses
via the T regulatory (Treg) cell pathway [10, 11]. In sup-
port of this, Lowder et al. used an allergic asthma mouse
model to demonstrate that moderate intensity activity
over 4 weeks resulted in increased number and function
of Tregs isolated from the lung and mediastinal lymph
nodes [11]. Similarly, in a study of adults, increased Treg
polarization of lymphocytes was observed with regular
physical activity over a 12-week period while there was
no change in a less active control group [12]. In con-
trast, reduced Treg cell number and function has been
linked to environmental pollution exposure. For ex-
ample, Nadeau and colleagues reported significant im-
pairment in Treg function among children with asthma
in the highly polluted region of Fresno, California, com-
pared to children living in the less polluted Stamford,
California region [13]. The same group also linked im-
paired Treg function to high exposure to the polycyclic
aromatic hydrocarbon (PAH) class of air pollutants [14].
Furthermore, both animal [15, 16] and human studies
[17] have demonstrated that Tregs suppress airway in-
flammation and airway hyper-responsiveness in allergic
asthma. Thus, altered Treg cell activity appears to
underlie how exposure to pollution impacts the relation-
ship between physical activity and airway disease.
Activation of the forkhead box p3 (FOXP3) transcription
factor controls the differentiation and function of Treg
cells [18]; thus, FOXP3 expression is an established marker
of committed Treg cell populations and function [19]. Sev-
eral studies have demonstrated that FOXP3 is regulated
through epigenetic mechanisms [20, 21]. For example, in
vitro models have established that demethylation of the
FOXP3 promoter is critical to the stable expression of
FOXP3 and the suppressive function of Tregs [22]. Among
ex vivo Treg cells, increased FOXP3 promoter methylation
has been inversely correlated with FOXP3 expression [23].
In addition, increased FOXP3 methylation has been linked
directly to higher pollutant exposures including diesel ex-
haust particles [24], polycyclic aromatic hydrocarbons
(PAHs) [13, 14], and secondhand smoke (SHS) [23]. Black
carbon (BC), like PAHs, is a component of particulate mat-
ter (PM) and a major element of “soot” which is an incom-
plete combustion product emitted from diesel exhaust.
Similar to SHS, BC exposure has been associated with re-
spiratory symptoms [25], airway inflammation [26], and re-
duced lung function [27]. Thus, BC exposure also may
contribute to the pollution-associated increase in FOXP3
methylation and Treg impairment.
Our primary objective was to determine the inter-
action between physical activity and BC exposure on
FOXP3 promoter methylation in a cross-sectional sam-
ple of 9–14-year-old children that live in New York City
(NYC). An additional objective was to determine the re-
lationship between FOXP3 promoter methylation and
measures of lung function. We assessed FOXP3 methyla-
tion in buccal cells as a surrogate for airway epithelium.
FOXP3 expression in buccal epithelium has been dem-
onstrated by others [28], and FOXP3 methylation in sal-
iva has been linked previously to both exposure to
pollution and asthma outcomes [24]. While physical ac-
tivity may induce improved immune function through
increased Treg activity, increased lung deposition of pol-
lutants during physical activity could mitigate this pro-
tective effect. Therefore, we hypothesized that overall,
physical activity would be associated with lower FOXP3
promoter methylation, but that this association would
lessen among those with high BC exposure. We also hy-
pothesized that lower FOXP3 promoter methylation
would be associated with higher lung function.
Methods
Study population
Study participants (n = 163) were enrolled from the
Columbia Center for Children’s Environmental Health
(CCCEH) birth cohort that is comprised of children living
in Northern Manhattan and the South Bronx of NYC,
whose non-smoking, African American and Dominican
mothers were recruited during pregnancy [29, 30]. Partici-
pants were recruited for this nested study based on age
(target 9-14-year-olds) and current asthma. Asthma diag-
nosis was determined by a physician (allergist or pulmo-
nologist) using standardized criteria during at least one
cohort study visit between ages 5 and 12 years [31]. In
addition, in order to be eligible for the nested study, chil-
dren with asthma had to have report of asthma symptoms
or asthma medication use in the 12 months prior to en-
rollment in the nested study. Total serum immunoglobu-
lin E (IgE) was measured at age 9 or 11. Children with a
total IgE level ≥80 IU/mL were considered seroatopic.
Children with body mass index (BMI) percentiles ≥the
85th percentile for age and sex were classified as “over-
weight.” Secondhand smoke exposure (SHS) was deter-
mined by answering yes to the question, “In the last 2
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weeks have you been exposed to tobacco smoke in the
home.” Complete data on physical activity, BC exposure,
DNA methylation, and lung function were available for n
= 135 children that were included in this study. The longi-
tudinal birth cohort study is conducted in accordance with
the Columbia University Institutional Review Board guide-
lines, and written informed consents and assents were
obtained.
Physical activity assessment
All study participants wore an accelerometer (Actical,
Philips Respironics, Bend, OR) continuously on the non-
dominant wrist for six consecutive days (Additional file 1:
Figure S1). To account for 24-h data that were partially
collected on the first and last day, only the five intervening
consecutive days with full 24-h of data were used for ana-
lysis [6, 32]. The accelerometer uses a sensor to detect
and integrate amplitude and frequency of motion and
stores the data as activity counts. Based on the activity
counts, activity energy expenditure is determined with a
cut point of <0.031 kcal/min/kg for light activity,
>0.083 kcal/min/kg for vigorous activity, and moderate in-
tensity activity in between. Summary statistics derived
from the Actical software were used to quantify the
amount of time spent in moderate and vigorous activity
for each 24-h period. Physical activity was characterized
based on the Center for Disease Control and Prevention
(CDC) recommendation that children should participate
in at least 60 min of moderate-to-vigorous activity (MVA)
on a daily basis (http://www.cdc.gov/physicalactivity/
everyone/guidelines/children.html). Children that met the
physical activity recommendation, having at least 60 min
of MVA daily, were considered “active” while children that
did not meet the physical activity recommendation were
considered “non-active” as previously published [6].
Personal BC monitoring
Personal exposure to BC was measured over two 24-h pe-
riods at the beginning and end of the week-long physical
activity monitoring period (Additional file 1: Figure S1).
Children carried a MicroAeth (Model AE51, Magee Scien-
tific, Berkley, CA) inside a vest pocket that contained an
air inlet in the breathing zone (vest collar). Children were
instructed to remove the vest during vigorous activity and
to keep it nearby and uncovered. We previously have
demonstrated excellent compliance with wearing the BC
monitoring equipment [33]. BC was sampled from the air
every 5 min and data were cleaned according to algo-
rithms developed to account for false positive and negative
measures that can result from physical vibration [34, 35].
Every 5 min, data were then averaged to yield a mean 24-
h exposure assessment. Mean 24-h personal exposure to
BC weakly correlated across the 2 days of measurement
(Spearman r = 0.35, p < 0.01), reflecting some day to day
variation in exposure. Therefore, personal BC exposure
levels were averaged across the two 24-h monitoring pe-
riods and dichotomized at the median (1210 ng/m3) to
represent high vs. low average exposure across the week.
Fifty-three percent of the personal BC exposure measure-
ments (n = 71) were sampled during the NYC cold wea-
ther heating season (i.e., from October to April).
FOXP3 DNA methylation analysis
Buccal samples were collected using the CytoSoft Cy-
tology brush [36, 37] (Fisher Scientific, Pittsburgh, PA,
USA) from each child at two time points, 5 days apart
corresponding to the 2 days of BC exposure assessment
(Additional file 1: Figure S1). Samples contained ap-
proximately 94% squamous epithelial cells, determined
by slide smear hematoxylin and eosin stain, as previously
published [38]. Bisulfite conversion was performed on
200 ng of genomic buccal cell DNA using Zymo
Research’s EZ DNA Methylation-Lightning Kit (Irvine,
CA, USA) as previously published [37, 38].
Polymerase chain reaction (PCR) primers and pyrose-
quencing primers (Additional file 2: Table S1) were de-
signed using PyroMark Assay Design 2.0 software
(Qiagen, Valencia, CA, USA) to target six CpG sites in
the promoter region of the FOXP3 gene. The promoter
region was defined as the gene region directly upstream
of the transcription start site (TSS) (Additional file 1:
Figure S2). The individual CpG sites were selected based
on previous literature that demonstrated methylation in
this region was associated with ambient air pollution ex-
posure [13]. We chose to focus on CpG sites in the gene
promoter which is the principal activator of FOXP3 ex-
pression [22] as opposed to CpG sites in the Treg-cell-
specific demethylated region (TSDR) which play a role
in stabilizing FOXP3 expression [39] and are only acti-
vated in Treg cells [40]. PCR reactions were performed
with Qiagen Hot Star Taq DNA polymerase reagents
(Qiagen Sciences, Germantown, MD, USA) with the fol-
lowing concentrations for each ingredient in the PCR
mixtures: 1× PCR buffer, 1.5 μM MgCl2, 200 μM dNTP,
0.2 μM forward primer, and 0.2 μM reverse primer. PCR
was performed under the following conditions: 95 °C,
5 min; 45 cycles of 95 °C, 30 s; 57 °C, 1 min; 72 °C,
1 min; 72 °C, 10 min; and 4 °C hold. The PCR product
was sequenced using PyroMark Q96 Pyrosequencer. Epi-
Tect high and low methylated control DNA (Qiagen Sci-
ences, Germantown, MD, USA) were included with
every pyrosequencing experiment.
Three distinct promoter regions were defined by the
proximity to neighboring CpG sites: promoter 1 in-
cluded CpGs −138 and −126; promoter 2 included CpGs
−77, −65, and −58; and promoter 3 included CpG −15
(Additional file 1: Figure S2). Percent methylation was
moderately correlated across each promoter region (r =
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0.22−0.45, p < 0.01). Therefore, percent methylation was
averaged across the two CpG sites in promoter 1 and
the three CpG sites in promoter 2. Percent methylation
measured across the two separate days was moderately
correlated for each of the promoter regions (r = 0.47−0.68,
p < 0.01) (Additional file 2: Table S2). Therefore, in order
to account for short-term variability in methylation across
the 1 week of physical activity monitoring [36], methyla-
tion was averaged across the 2 days. For subjects in which
there was only 1 day of methylation data available because
of a laboratory technical failure (n = 8 for promoter 1 and
n = 2 for promoter 2), the one available methylation value
was used in place of an average.
FOXP3 mRNA expression analysis
A separate buccal swab was collected from each child and
stored in RNAlater solution (Qiagen Sciences, German-
town, Maryland, United States). RNA was extracted using
the Trizol method (Invitrogen, Life Technologies Europe
BV, Monza, Italy) as previously published [37]. RNA con-
centration and purity was measured using a NanoDrop
spectrophotometer (Thermo Scientific, Wilmington, DE,
USA). Complementary (cDNA) synthesis of up to 200 μg of
RNA was transcribed with a SuperScript First-Strand Syn-
thesis System for RT-PCR (Invitrogen, Life Technologies
Europe BV, Monza, Italy) according to the manufacturer’s
instructions. Quantitative real-time PCR was performed
using a 25-μl reaction volume containing 2 μl cDNA tem-
plate, 12.5 μl SYBR Green Mix (Applied Biosystems, Foster
City, CA, USA), 9.5 μl H20, and 0.2 μM of forward and re-
verse primer (Additional file 2: Table S1). Amplifications
were performed in duplicate with an initial incubation at
95 °C for 30 s, followed by 40 cycles of 95 °C for 10 s and
55 °C for 30 s, using a CFX Connect Real-Time PCR Detec-
tion System (Bio-Rad, Hercules, CA, USA).
FOXP3 mRNA expression levels were determined
using the 2−ΔCt method with cystatin A (CSTA) as a ref-
erence gene (highly and stably expressed in non-
malignant epithelial tissue [41]) and normalized to the
lowest measured value. Across the 2 days of sampling,
relative mRNA expression was moderately correlated
(r = 0.31, p < 0.01, Additional file 2: Table S2); there-
fore, values were averaged across the 2 days. For the
subjects for which there was insufficient template RNA
and cDNA to perform real-time PCR experiments for one
of the measurement days (n = 6), we used a single value in
place of a 2-day average yielding a total sample size of 132
for all RNA analysis.
Pulmonary function assessment
Spirometry was used to assess pulmonary function during
in-home visits on days 1 and 6, immediately following BC
assessment (Additional file 1: Figure S1). Studies were per-
formed using a portable spirometer (Koko, nSpire Health,
Longmont, CO, USA), in accordance with ATS and ERS
guidelines [31]. Four spirometry outcome measures were
used for this analysis, forced vital capacity (FVC), forced
expiratory volume in 1 s (FEV1), the ratio of FEV1/FVC,
and the forced expiratory flow at 25–75% (FEF25–75%).
Spirometry results were interpreted independently by two
pulmonologists to ensure acceptability criteria were met
based on ATS and ERS guidelines [42].
Statistical analysis
Chi-square and t tests were used to explore differences in
demographic characteristics between the active and non-
active children. Spearman correlations were used to assess
methylation correlations across promoter regions. Kruskal-
Wallis tests were used to determine the difference in
FOXP3 promoter methylation between active vs. non-active
children and between high vs. low BC concentrations.
Step-wise multivariable linear regression models were
fit to examine the association between physical activity
and FOXP3 promoter methylation with active (coded 1)
vs. non-active (coded 0) as the main predictor of inter-
est. Models were further stratified by high vs. low BC
concentrations (dichotomized at the median). To assess
for interaction, we introduced a cross product term of
activity x BC concentration to our non-stratified models.
Because FOXP3 promoter methylation was not normally
distributed, we also performed a sensitivity analysis
using ordinal logistic regression where methylation was
categorized by quartiles. To examine the association of
FOXP3 promoter methylation on lung function, we
again performed step-wise linear regression models with
percent methylation as the predictors of interest and
FVC, FEV1, FEV1/FVC, and FEF25–75% percent predicted
as the outcomes.
To explore potential associations between activity, pol-
lution, and FOXP3 expression, in the secondary analysis,
we substituted relative mRNA expression for methyla-
tion in our above mentioned models. We also performed
a secondary analysis to examine the relationship between
physical activity and lung function. As an exploratory
analysis, we further stratified our activity-lung function
model by the upper tertile of BC concentration
(≥1790 ng/m3) to isolate the children with the most ex-
treme BC exposure concentrations. For these explora-
tory analyses, we chose to stratify by the upper tertile of
BC based on our previous findings that physical activity
was associated with decrease airway inflammation but
not among children with the highest exposure to BC
(upper tertile) [6]. Lastly, given that the FOXP3 gene is
located on the X-chromosome and may be susceptible
to X-chromosome inactivation (XCI) resulting in sex dif-
ferences in methylation patterns [43, 44], we performed
ancillary analyses stratified by sex. All final models were
adjusted for the following covariates: age, sex (except in
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models stratified by sex), race/ethnicity, height (lung
function models only), body mass index (BMI) Z-score
[45], asthma, atopy (total IgE ≥80 IU/mL), personal BC
concentration (except in the models stratified by BC),
SHS exposure, and heating season.
All statistical analyses were performed using SAS 9.4.
Results
Subject characteristics
Demographic characteristics for the 135 children in-
cluded in this analysis are provided in Table 1. The
children in the active group were slightly younger than
the children in the non-active group (p < 0.01). There
were fewer children in the non-active group with SHS
exposure compared to children in the active group (p =
0.04). Average time spent (±SD) in MVA across the 5-
day observation period among active children was
210 min/day (±84) and among non-active children was
101 min/day (±58).
Independent associations of physical activity and BC
exposure on FOXP3 methylation
Buccal cell methylation in the FOXP3 promoter regions
ranged from 62.9 to 95.1% (promoter 1: mean ± SD, 80.0 ±
4.8; promoter 2: 87.4 ± 4.0; promoter 3: 80.2 ± 5.9). We ob-
served moderate correlations in FOXP3 methylation across
the three promoter regions (rspearman 0.56–0.58, p < 0.01)
(Additional file 1: Figure S3). In bivariate analysis, active
children had lower promoter 3 methylation (79.2 ± 6.1)
compared to non-active children (81.4 ± 5.4, p = 0.04)
(Fig. 1). Also, children with high personal BC exposure had
higher promoter 1 methylation compared to children with
low BC (80.9 ± 4.8 vs. 79.1 ± 4.7, p = 0.04) (Fig. 1).
In multivariable linear regression models, we did not
observe an association between physical activity and
FOXP3 promoter methylation (p = 0.31, 0.33, and 0.35
for promoters 1, 2, and 3, respectively) (Table 2).
Combined association of physical activity and BC
exposure on FOXP3 methylation
We first compared FOXP3 promoter methylation across
four groups of children (non-active/low BC, active/low
BC, non-active/high BC, and active/high BC) (Fig. 2).
Non-active children with high exposure to BC had the
highest methylation in all FOXP3 promoter sites (p <
0.05, Fig. 2). We next performed multivariable linear re-
gression models to examine the association between
physical activity and FOXP3 methylation stratified by
high vs. low BC concentrations. Among children with
high personal BC measures (n = 63), active children on
average had 2.4% lower promoter 2 methylation (βestimate
[95% CI], −2.37 [−4.04, −0.70], p < 0.01) and 2.6% lower
promoter 3 methylation (−2.57 [−4.62, −0.51], p = 0.01)
compared to non-active children (Table 2). There was
no significant association between physical activity and
FOXP3 methylation among children with low personal
BC concentration (p > 0.05) (Table 2). We observed a
significant interaction in the association between activity
and promoter 2 methylation by BC concentration (pinter-
action = 0.04), but not with promoter 3 methylation (pinter-
action = 0.26) (Table 2).
In sensitivity analysis using ordinal logistic regression,
we again observed a trend towards an inverse association
between activity and methylation among children with
high BC (p = 0.09, 0.06, and 0.07 for promoters 1, 2, and
3, respectively) (Additional file 2: Table S3). There was
no association between activity and methylation among
children with low BC (p > 0.05).
Association between FOXP3 methylation and lung
function
We next examined the association between FOXP3 pro-
moter methylation and lung function outcomes. There
was an inverse association between FOXP3 promoter 2
Table 1 Participant characteristics for the n = 135 children






Age in years, median (range) 12.7 (10.5–14.0) 12.2 (9.2–14.0) <0.01









Asthmab, n (%) 30 (52%) 45 (58%) 0.44
FVC % predicted, mean (SD) 85% (12.1) 86% (10.5) 0.92
FEV1 % predicted, mean (SD) 84% (13.0) 85% (11.6) 0.72
FEV1/FVC % predicted, mean
(SD)
87% (7.5) 87% (5.3) 0.52
FEF25–75% % predicted, mean
(SD)
83% (24.2) 86% (21.7) 0.36
Total IgE ≥80 IU/mL 31 (53%) 38 (49%) 0.64
BMI ≥85th percentile, n (%) 31 (53%) 39 (51%) 0.75
Secondhand smokec, n (%) 3 (5%) 14 (18%) 0.04
Heating seasond, n (%) 25 (43%) 44 (57%) 0.11
Black carbon, GM (SD) 1070 (1.69) 1190 (1.78) 0.25
High BCe, n (%) 26 (45%) 37 (48%) 0.71
FVC forced vital capacity, FVE1 forced expiratory volume in 1 s, FEF25–75% forced
expiratory flow at 25–75%, IgE Immunoglobulin E, BMI body mass index, BC
black carbon
aChi-square test for categorical variables and t test for continuous variables
(age and black carbon)
bDetermined by a physician at age 5–12 years using a priori
standardized criteria
cDetermined by responding yes to the question “In the last 2 weeks have you
been exposed to tobacco smoke in the home.” missing n = 1 from the
active group
dObservation period took place during NYC’s cold weather heating season
(October to April)
eDichotomized at the median, 1210 ng/m3
Italicised values in the final column represent a p-value < 0.05
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methylation and both the FEV1/FVC and FEF25–75%
(Fig. 3). On average, for every 10% increase in FOXP3
promoter 2 methylation, there was a 4% decrease in
FEV1/FVC (βestimate [95% CI], −0.40 [−0.67, −0.13], p <
0.01). Similarly, for every 10% increase in FOXP3 pro-
moter 2 methylation, there was a 15% decrease in
FEF25–75% (−1.46 [−2.52,−0.40], p < 0.01) (Additional file 2:
Table S4). Also, in our crude models, there were inverse
associations between promoter 1 methylation and both
FEV1/FVC (−0.18 [−0.30, −0.05], p < 0.01) and FEF25–75%
(−0.04 [−0.07, −0.00], p = 0.03); however, these findings
were not statistically significant after controlling for
confounders. There was no significant association
between promoter 3 methylation and lung function
nor between methylation and FVC or FEV1. Also, the
relationship between promoter 2 methylation and
lung function did not significantly vary by high vs.
low BC exposure (Additional file 2: Table S5).
Secondary analyses
First, we performed substitution analysis with FOXP3
relative expression. However, we did not observe a cor-
relation between FOXP3 methylation of any of the three
promoter sites with relative mRNA expression (pro-
moter 1: r = −0.03, p = 0.74; promoter 2: r = −0.10, p =


































































Fig. 1 Distribution of FOXP3 promoter methylation stratified by active vs. non-active children and by low vs. high black carbon (Kruskal-Wallis test).
The short lines indicate individual observations, while the shaded areas indicated the distribution of the data for each respective group. The dotted
lines indicate the mean percent methylation for all participants, and the thicker solid lines represent mean percent methylation for each respective group
Table 2 Active children with high exposure to BC have lower FOXP3 promoter methylation compared to non-active children
with high BC
Difference in percent methylation in active vs. non-active children








Promoter 1 −0.59 (−1.72, 0.54) −1.32 (−2.74, 0.11) 0.30 (−1.36, 1.97) NA
Promoter 2 −0.60 (−1.79, 0.60) −2.37 (−4.04, −0.70) 0.54 (−1.12, 2.20) 0.04
Promoter 3 −0.68 (−2.10, 0.74) −2.57 (−4.62, −0.51) −0.41 (−2.16, 1.34) 0.26
βestimate represents the effect size or the difference in percent methylation when comparing active children to non-active children (reference). Models adjusted for
age, sex, race/ethnicity, BMI Z-score, asthma, atopy, secondhand smoke exposure, BC (only in non-stratified model), and heating season. Italicized values represent
p value ≤0.01 and p < 0.05 for interaction term. Pinteraction represents the p value for the interaction term between physical activity and BC
aDichotomized at the median, 1210 ng/m3































































Low BC High BC
Fig. 2 Non-active children with high BC on average have the highest FOXP3 promoter methylation (Kruskal-Wallis test). The short lines indicate
individual observations, while the shaded areas indicated the distribution of the data for each respective group. The dotted lines indicate the
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Fig. 3 Lower FOXP3 promoter methylation is associated with higher FEV1/FVC and FEF25−75%. The blue line represents the mean effect estimate,
and the shaded gray area represents the 95% confidence interval (n = 135)
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secondary analyses, we substituted FOXP3-relative mRNA
expression in our models to explore the relationship with
combined activity and BC concentrations as well as lung
function. There was no significant association between
physical activity and mRNA expression in the high (βesti-
mate [95% CI], 0.02 [−0.00, 0.05], p = 0.11) or low (−0.00
[−0.01, 0.00], p = 0.12) personal BC groups. There was no
significant association between relative mRNA expression
and lung function (data not shown).
Second, we explored the overall relationship between
physical activity and lung function using multivariable lin-
ear regression models. We observed a significant positive
association between physical activity and FEF25–75%. On
average, active children had 8% greater FEF25–75% com-
pared to non-active children (8.07 [0.40, 15.74], p = 0.04)
(Table 3). To explore relationships among the children
with the most extreme pollutant measures and highest risk
based on previous findings [6], we further stratified our
model by the upper tertile of BC concentration. Interest-
ingly, among children with the highest BC exposure, active
children had lower FEV1 and FVC compared to non-active
children. Conversely, among children with lower BC ex-
posure, active children had higher FEV1 and FEF25–75%
compared to non-active children (Table 3). However, there
was no significant interaction between activity and BC ex-
posure on any of the lung function outcomes (Table 3).
Lastly, in ancillary analyses stratified by sex, we observed
that FOXP3 promoter methylation was lower in females
compared to males (p < 0.01, Additional file 1: Figures S4
and S5), and the relationships between activity, FOXP3
promoter methylation, and lung function were stron-
ger among females compared to those among males
(Additional file 2: Table S6, Additional file 2: Table S7).
Discussion
In our cohort of 9–14-year-old children of African
American and Dominican descent living in NYC, we
identified a link between higher combined personal BC
exposure and physical activity and lower FOXP3 pro-
moter methylation. In addition, FOXP3 promoter
methylation was inversely associated with FEV1/FVC
and FEF25–75%, the two indicators of airway obstructive
physiology [46, 47]. These findings suggest that higher
exposure to air pollution may be a condition by which
urban children are more likely to gain immunological
benefits of regular exercise, and that FOXP3 promoter
methylation may function as a biomarker of that benefit.
Our a priori hypothesis was that active children would
have lower FOXP3 buccal cell methylation compared to
non-active children. Our findings were consistent with
this hypothesis only within the promoter 3 region, which
is the CpG site most proximal to the transcription start
site. An additional hypothesis was that high BC expos-
ure, which has been associated with adverse respiratory
outcomes [25–27], would attenuate the association be-
tween physical activity and methylation. Contrary to our
hypothesis, the association between physical activity and
FOXP3 methylation was only notable among children
with high BC exposure. This may instead suggest that,
although physical activity may increase lung deposition
of ambient pollutants and thereby increase airway in-
flammation, a high degree of regular physical activity
may induce sufficient protective immune balance to
mitigate this effect. FOXP3 promoter methylation levels
among active children with high BC were comparable to
both groups of children with low BC (active and non-
active) (Fig. 2). Thus, we speculate that children with
higher risk of Treg impairment due to high exposure to
pollutants are the ones able to achieve greater immuno-
logic benefit from regular physical activity. Fisher and
colleges recently investigated the interaction between
physical activity and nitrogen dioxide (NO2) pollutant
exposure on respiratory-related hospitalization in a co-
hort of Danish adults [48]. The authors reported no sig-
nificant interaction between physical activity and
pollutant exposure on hospitalizations for asthma sug-
gesting that the benefits of activity outweighed the risk
of pollutant exposure. Through our ability to assess re-
cent activity and acute air pollution with high granular-
ity, our findings further suggest a significant short-term
Table 3 Among children with the upper tertile of exposure to BC, physical activity is associated with reduced lung function,
whereas children with less BC exposure experience opposite effects
Difference in methylation in active vs. non-active children
βestimate (95% confidence interval)





FEV1 2.72 (−1.14, 6.59) −7.87 (−15.33, −0.42) 4.60 (0.21, 8.99) 0.09
FVC 1.25 (−2.25, 4.75) −6.91 (−13.70, −0.13) 2.70 (−1.30, 6.70) 0.31
FEV1/FVC 1.36 (−0.62, 3.33) −1.09 (−5.03, 2.5) 1.90 (−0.49, 4.28) NA
FEF25−75% 8.07 (0.40, 15.74) −6.59 (−23.0, 9.80) 9.60 (0.60, 18.60) 0.27
βestimate represents the effect size or the difference in percent methylation when comparing active children to non-active children (reference). Models adjusted for
age, sex, race/ethnicity, BMI Z-score, asthma, atopy, secondhand smoke exposure, heating season, and BC concentration (only for overall sample model). Italicized
values represent p value ≤0.05. Pinteraction represents the p value for the interaction term between physical activity and BC
aDichotomized at the upper tertile, 1790 ng/m3
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positive interaction between pollutant exposure and ac-
tivity on immune function, as indicated by FOXP3 pro-
moter methylation.
Divergent from previous reports in humans [23], we
were unable to detect a correlation between buccal FOXP3
promoter methylation and relative mRNA expression. One
possible explanation is that the above mentioned relation-
ship previously has been identified in isolated Treg cells
while we sampled buccal cells. Also, currently, there is no
standardized method for quantifying methylation across
CpG sites within a gene region, thus limiting the ability to
compare percent methylation levels across various studies
[13, 23]. To our knowledge, this is one of the first studies
to investigate FOXP3 methylation in buccal epithelium;
however, our absolute percent methylation levels are com-
parable to those measured in gingival epithelial cells [49].
Methylation patterns can differ by cell type [37, 50], which
is likely reflective of lower mRNA expression of immuno-
modulatory genes in buccal epithelium vs. higher expres-
sion among lymphocytes. We previously reported higher
methylation in buccal cells compared to CD4+ lympho-
cytes within the interferon gamma (IFNγ) immunomodula-
tory gene promoter. Additionally, a significant correlation
in IFNγ methylation across the cell types was notable for
one of the CpG sites [37], suggesting a link between buccal
cell and lymphocyte methylation in that particular gene.
Buccal cells are easily accessible, apt for repeat testing with
changing environmental exposures and less invasive than
sampling the blood or lower airway epithelial cells. Thus,
they may represent a suitable source of a biomarker for
pediatric cohort research.
Notably, our most significant findings were observed
in the promoter 2 region that encompasses two of three
CpG sites (−77 and −65) that are conserved in humans,
mice, and rats [22]. Others also have reported that indi-
vidual CpG sites within a gene region may be critical
drivers of downstream effects [51, 52]. Our methylation
signal was small, and our observed differences in FOXP3
promoter methylation between active and non-active
children was about 2.5% [51, 52]. Breton and colleagues
also described small differences in buccal cell methyla-
tion of several genes between children that were exposed
vs. those not exposed to secondhand smoke [53]. None-
theless, the observation that buccal cells were not com-
pletely methylated may suggest that we are capturing a
small signal that could reflect larger differences among
immune-specific cells. In addition, our observations be-
tween methylation and lung function suggest that small
changes in buccal epithelial methylation alone could be
clinically meaningful. This is consistent with a recent re-
view article that appraised the clinical significance of
small-magnitude effect sizes in pediatric environmental
epigenetic research, similar to those reported in this
current study [54].
Further, the FOXP3 gene is located on the X-
chromosome and thus, may be susceptible to X-
chromosome inactivation (XCI) in females. This too may
be driven and maintained by DNA methylation [44]. How-
ever, sex differences in methylation attributed to XCI can
vary by location within a gene [55]. In our cohort, we ob-
served lower FOXP3 promoter methylation in females
compared to males (Additional file 1: Figures S4 and S5),
consistent with the findings in a different cohort of chil-
dren. In that cohort, differences were more striking and in
the opposite direction within the FOXP3 enhancer region
[43]. In this current study, the association between phys-
ical activity and FOXP3 methylation among children with
high BC was most notable in females compared to males
(Additional file 1: Figures S6 and S7, Additional file 2:
Table S6). Likewise, the relationship between FOXP3 pro-
moter methylation and lung function was stronger in the
females (Additional file 2: Table S7). Overall, these find-
ings underscore the importance of considering sex effects
in methylation studies, particularly within genes that are
susceptible to XCI.
Breton and colleagues also identified a significant in-
verse relationship between buccal cell DNA methylation
of another asthma gene, arginase (ARG)2, and airway in-
flammation measured by fractional exhaled nitric oxide
(FeNO) [56]. Similarly, Baccarelli and colleagues identified
an association between nasal epithelial cell methylation of
inducible nitric oxide synthase (iNOS) and interleukin
(IL)6 with FeNO, but not with lung function (FEV1) [57].
While we too did not appreciate a significant association
in methylation of our candidate genes, FOXP3 and FEV1;
we did, however, observe associations with FEV1/FVC and
FEF25–75%. Both FEV1/FVC [46] and FEF25–75% [47] have
been demonstrated as better predictors of airway obstruc-
tion [47] and asthma severity [46] compared to FEV1. Fur-
thermore, we observed that active children had higher
FEF25–75% compared to non-active children which sup-
ports our previous finding of a protective effect of physical
activity on airway inflammation [6].
While we believe that our findings are fairly robust,
several limitations of our study need to be acknowl-
edged. First, our cross-sectional study design limits our
ability to infer causality because of concerns regarding
temporality. However, it is unlikely that one’s DNA
methylation could cause a person to be more or less ac-
tive or have greater or lesser exposure to air pollution.
Also, in the current analysis DNA methylation was aver-
aged across two measurements 5 days apart. This ap-
proach was taken to account for variation in
methylation that can occur across short time intervals
[36]. Also, while we compared FOXP3 promoter methy-
lation to FOXP3 expression among buccal cells, we did
not correlate buccal cell FOXP3 methylation with Treg
function directly. We acknowledge that our FOXP3 buccal
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cell methylation is not equivalent for measuring altered
Treg function related to physical activity, lung function,
and exposure to pollutants in immune tissues. Rather, our
findings suggest that FOXP3 promoter methylation should
be further explored as a biomarker of activity-mediated im-
mune regulation. Generalizability of our findings is limited
given our selected population of African American and Do-
minican children that live in an urban environment. How-
ever, one rationale for this selective cohort is that minority
children in urban populations that we sampled here are at
the greatest risk for asthma-associated morbidity [58, 59].
Similarly, the exploratory observations between physical ac-
tivity and lung function that differed by high and low BC
concentrations may be even more robust in a larger sample
of children. However, the parent study was not designed or
adequately powered to assess these relationships.
Conclusions
We have demonstrated that combined physical activity
and personal BC exposure may influence FOXP3 pro-
moter DNA methylation and that FOXP3 promoter
methylation is related to lung function. Our study has
identified a unique subgroup of children with high BC
exposure that may benefit the most from regular phys-
ical activity. While the mechanisms are unknown, these
findings suggest that exercise may be associated with a
protective immune response in the setting of high pollu-
tion exposure. FOXP3 promoter methylation may be a
useful biomarker of this protection. Overall, our findings
are supportive of both the use of buccal cells for DNA
methylation studies as well as a possible role of DNA
methylation in respiratory outcomes.
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Additional file 1: Figure S1. Sampling scheme for accelerometer, black
carbon (BC), buccal swabs for DNA and RNA analysis and spirometry.
Figure S2. Schematic representation of the FOXP3 gene and the six CpG
sites in the promoter region that were investigated. TSS transcription start
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regions and with mRNA relative expression. Figure S4. Distribution of
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Table S7. The relationship between FOXP3 promoter methylation and lung
function is greater among females compared to that among males.
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